Literature DB >> 8616715

Cortisol blockade of progesterone: a possible molecular mechanism involved in the initiation of human labor.

K Karalis1, G Goodwin, J A Majzoub.   

Abstract

In most mammals, labor is heralded by progesterone withdrawal, which is believed to be related to the activation of multiple pathways leading to parturition. In humans, despite no decrease in placental progesterone production, activation of similar pathways preceding labor suggests the presence of an endogenous antiprogestin, which we reasoned might be cortisol, whose secretion from the fetal adrenal rises markedly at the end of human gestation. We report that in primary cultures of human placenta, cortisol is able to compete with the action of progesterone in the regulation of the corticotropin-releasing hormone (CRH) gene. CRH is a peptide highly expressed in human placenta at the end of gestation, which has been suggested to be involved in regulating the timing of parturition. These findings provide a model for functional progesterone withdrawal at the end of human pregnancy, which may be involved in the initiation of labor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616715     DOI: 10.1038/nm0596-556

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  41 in total

Review 1.  Hormones and human trophoblast differentiation: a review.

Authors:  André Malassiné; Laurent Cronier
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  The plastic fetal pituitary.

Authors:  Drew V Tortoriello
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

3.  Fetal-placental inflammation, but not adrenal activation, is associated with extreme preterm delivery.

Authors:  Sunita Trivedi; Maria Joachim; Thomas McElrath; Harvey J Kliman; Elizabeth N Allred; Raina N Fichorova; Andrew Onderdonk; Fernanda Heitor; Leila Chaychi; Alan Leviton; Joseph A Majzoub
Journal:  Am J Obstet Gynecol       Date:  2011-12-16       Impact factor: 8.661

Review 4.  The preterm parturition syndrome.

Authors:  R Romero; J Espinoza; J P Kusanovic; F Gotsch; S Hassan; O Erez; T Chaiworapongsa; M Mazor
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

5.  Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins.

Authors:  Barbara J Attardi; Anthony Zeleznik; Hyagriv Simhan; Jye Ping Chiao; Donald R Mattison; Steve N Caritis
Journal:  Am J Obstet Gynecol       Date:  2007-12       Impact factor: 8.661

6.  A case of Cushing's syndrome presenting as endometrial hyperplasia.

Authors:  Sang Min Lee; Jong Ryeal Hahm; Tae Sik Jung; Jung Hwa Jung; Mi Yeon Kang; Sun Joo Kim; Soon Il Chung
Journal:  Korean J Intern Med       Date:  2008-03       Impact factor: 2.884

7.  Levels of maternal serum corticotropin-releasing hormone (CRH) at midpregnancy in relation to maternal characteristics.

Authors:  Yumin Chen; Claudia Holzman; Hwan Chung; Patricia Senagore; Nicole M Talge; Theresa Siler-Khodr
Journal:  Psychoneuroendocrinology       Date:  2009-12-16       Impact factor: 4.905

8.  Overexpression of thioredoxin-1 reduces oxidative stress in the placenta of transgenic mice and promotes fetal growth via glucose metabolism.

Authors:  Takashi Umekawa; Takashi Sugiyama; Tomohisa Kihira; Nao Murabayashi; Lingyun Zhang; Kenji Nagao; Yuki Kamimoto; Ning Ma; Junji Yodoi; Norimasa Sagawa
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

9.  Progesterone and the Repression of Myometrial Inflammation: The Roles of MKP-1 and the AP-1 System.

Authors:  K Lei; E X Georgiou; L Chen; A Yulia; S R Sooranna; J J Brosens; P R Bennett; M R Johnson
Journal:  Mol Endocrinol       Date:  2015-08-17

10.  Detection of corticotropin-releasing hormone receptors R1 and R2 (CRH-R1, CRH-R2) using fluorescence immunohistochemistry in the myometrium of women delivering preterm or at term.

Authors:  Stefan Jirecek; Barbara Tringler; Martin Knöfler; Sandra Bauer; Ata Topcuoglu; Christian Egarter
Journal:  Wien Klin Wochenschr       Date:  2003-10-31       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.